Since the overexpression of EZH2 is associated with a more aggressive osteosarcoma tumor phenotype, we performed a CCK-8 assay, soft agar assay and cell cycle assay to determine whether EZH2 silencing can inhibit cell growth, colony formation and cell cycle arrest of osteosarcoma cells. This evidence concerns the gene EZH2 and osteosarcoma.